Fibroblast Growth Factor 4
"Fibroblast Growth Factor 4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A HEPARIN binding fibroblast growth factor that may play a role in LIMB BUDS development.
| Descriptor ID |
D051519
|
| MeSH Number(s) |
D12.644.276.624.140 D12.776.467.624.140 D12.776.624.664.700.110 D23.529.624.140
|
| Concept/Terms |
Fibroblast Growth Factor 4- Fibroblast Growth Factor 4
- Heparin Secretory Transforming Protein-1
- Heparin Secretory Transforming Protein 1
- Proto-Oncogene Protein Hst-1
- Hst-1, Proto-Oncogene Protein
- Proto Oncogene Protein Hst 1
- Kaposi's Sarcoma Fibroblast Growth Factor
- Proto-Oncogene Protein kfgf
- Proto Oncogene Protein kfgf
- kfgf, Proto-Oncogene Protein
|
Below are MeSH descriptors whose meaning is more general than "Fibroblast Growth Factor 4".
Below are MeSH descriptors whose meaning is more specific than "Fibroblast Growth Factor 4".
This graph shows the total number of publications written about "Fibroblast Growth Factor 4" by people in this website by year, and whether "Fibroblast Growth Factor 4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 5 | 5 |
| 2004 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibroblast Growth Factor 4" by people in Profiles.
-
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition. Cancer Discov. 2019 12; 9(12):1646-1649.
-
Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011 Feb 03; 470(7332):105-9.
-
Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol. 2005 Oct; 25(19):8507-19.
-
The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. Dev Biol. 2004 Sep 15; 273(2):361-72.
-
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol. 2003 Oct 15; 42(8):1339-47.
-
Overlapping effects of different members of the FGF family on lens fiber differentiation in transgenic mice. Development. 1998 Sep; 125(17):3365-77.
-
FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas. Oncogene. 1998 Aug 13; 17(6):761-7.
-
Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells. Oncogene. 1998 Jul 02; 16(26):3471-80.
-
The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7). Br J Cancer. 1998 Jul; 78(1):111-8.
-
Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science. 1998 May 22; 280(5367):1274-7.